119 related articles for article (PubMed ID: 8383247)
1. Effect of a capsid-stabilizing pyridazinamine, R 78206, on the eclipse and intracellular location of poliovirus.
Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
J Virol; 1993 Apr; 67(4):2367-9. PubMed ID: 8383247
[TBL] [Abstract][Full Text] [Related]
2. Poliovirus infection without accumulation of eclipse particles.
Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
Antiviral Res; 1995 Jan; 26(1):27-35. PubMed ID: 7741519
[TBL] [Abstract][Full Text] [Related]
3. Heat stabilized, infectious poliovirus.
Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
Vaccine; 1995 Aug; 13(11):983-6. PubMed ID: 8525692
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy between infectivity and antigenicity stabilization of oral poliovirus vaccine by a capsid-binding compound.
Andries K; Rombaut B; Dewindt B; Boeyé A
J Virol; 1994 May; 68(5):3397-400. PubMed ID: 8151800
[TBL] [Abstract][Full Text] [Related]
5. A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids.
Rombaut B; Andries K; Boeyé A
J Gen Virol; 1991 Sep; 72 ( Pt 9)():2153-7. PubMed ID: 1716654
[TBL] [Abstract][Full Text] [Related]
6. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
[TBL] [Abstract][Full Text] [Related]
7. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
[TBL] [Abstract][Full Text] [Related]
8. Internalization of intact poliovirus by HeLa cells as shown by subcellular fractionation in isoosmotic Nycodenz gradients.
Kronenberger P; Vrijsen R; Geerts A; Boeyé A
J Gen Virol; 1992 Mar; 73 ( Pt 3)():597-605. PubMed ID: 1312119
[TBL] [Abstract][Full Text] [Related]
9. Stabilisation of poliovirus with pirodavir.
Rombaut B; Andries K; Boeyé A
Dev Biol Stand; 1996; 87():173-80. PubMed ID: 8854015
[TBL] [Abstract][Full Text] [Related]
10. Intracellular proteolysis of poliovirus eclipse particles is abortive.
Kronenberger P; Vrijsen R; Boeyé A
J Gen Virol; 1994 Mar; 75 ( Pt 3)():573-80. PubMed ID: 8126453
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of poliovirus uncoating by disoxaril (WIN 51711).
Zeichhardt H; Otto MJ; McKinlay MA; Willingmann P; Habermehl KO
Virology; 1987 Sep; 160(1):281-5. PubMed ID: 2820136
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of poliovirus RNA synthesis by brefeldin A.
Maynell LA; Kirkegaard K; Klymkowsky MW
J Virol; 1992 Apr; 66(4):1985-94. PubMed ID: 1312615
[TBL] [Abstract][Full Text] [Related]
13. 6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.
González ME; Almela MJ; Yacout M; Carrasco L
Antimicrob Agents Chemother; 1990 Jun; 34(6):1259-61. PubMed ID: 2168147
[TBL] [Abstract][Full Text] [Related]
14. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
Dove AW; Racaniello VR
J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
[TBL] [Abstract][Full Text] [Related]
15. The antiviral compound 5-(3,4-dichlorophenyl) methylhydantoin inhibits the post-synthetic cleavages and the assembly of poliovirus in a cell-free system.
Verlinden Y; Cuconati A; Wimmer E; Rombaut B
Antiviral Res; 2000 Oct; 48(1):61-9. PubMed ID: 11080541
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine induces empty capsid formation during poliovirus eclipse.
Kronenberger P; Vrijsen R; Boeyé A
J Virol; 1991 Dec; 65(12):7008-11. PubMed ID: 1658391
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.
Andries K; Dewindt B; Snoeks J; Willebrords R; van Eemeren K; Stokbroekx R; Janssen PA
Antimicrob Agents Chemother; 1992 Jan; 36(1):100-7. PubMed ID: 1317142
[TBL] [Abstract][Full Text] [Related]
18. Effects of temperature and lipophilic agents on poliovirus formation and RNA synthesis in a cell-free system.
Molla A; Paul AV; Wimmer E
J Virol; 1993 Oct; 67(10):5932-8. PubMed ID: 8396661
[TBL] [Abstract][Full Text] [Related]
19. RNA binding properties of poliovirus subviral particles.
Nugent CI; Kirkegaard K
J Virol; 1995 Jan; 69(1):13-22. PubMed ID: 7983702
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of viral ribonucleic acid replication by Gliotoxin.
Miller PA; Milstrey KP; Trown PW
Science; 1968 Jan; 159(3813):431-2. PubMed ID: 4294481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
